The Report of Pharmaceutical Electronic Commerce in China(二)
Pharmaceutical online businesses is increased year by year.
By the January 31 of 2016, the enterprises ，which achieve the qualification certificate of pharmaceutical online trading about 525.
Among them, the number of A, B and C card is 26, 112 and 387 respectively , accounting for more than 5%, 21.3% and 73.7% respectively.C certification accounted for the largest proportion.
From the current point of view, although the online pharmacy market size is not large, but the growth rate is relatively fast.
In 2013, online pharmacy sales is 4.2 billion RMB.
In 2014 ,the figure was 7.2 billion.
In 2015, the size of the transaction will reach 11 billion RMB.
With the development of online pharmacies medicare payment pilot,pharmaceutical online suppliers still have a huge space for development.
Compass is a consulting & service agency for the corporations to enter Chinese market.
We can provide the one-stop services of investment inspection & business connection, collaborator recruiting & sales agent recruiting, mall entry, intellectual property protection, offline advertising, purchasing & Logistics, Chinese website design & promotion, and business translation.
If you corporation are interested in Chinese market and need help, please contact Compass.
Our specially-assigned staff will reach you within 24 hours.
Compass foreign business service center (Abbrev. Compass) is a comprehensive agency that can provide one-stop service for foreign businessmen from around the world. It’s the professional agency that get the permission to establish by Chinese government. Compass provides one-stop agency services for foreign businessmen in China- investment, purchasing, joining electronic commerce platform and marketing.
Compass will help the foreign businessmen’ to do their business operations in China easier. The professional teams that consisted of different realm experts will greatly shorten the time in different steps, reduce the business costs, and the business risk in the investment project in China.